Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Auxly Cannabis Group Inc T.XLY

Alternate Symbol(s):  CBWTF

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company also conducts wholesale bulk sales of dried cannabis to various licensed producers in Canada. Its subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., and Auxly Leamington Inc. The Company’s primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing and conducts the Company’s primary dried flower and pre-roll manufacturing.


TSX:XLY - Post by User

Bullboard Posts
Comment by EbbFlow88on Aug 31, 2020 10:29am
137 Views
Post# 31478980

RE:Auxly Double Over The Next Year

RE:Auxly Double Over The Next Year I still give credit to them for creating good products and building out a large platform, but the analyst himself sees big downside and is only keeping this outperform and 0.40$ due to Imperial. If you believe SG&A is coming down and they will limit dilution then this might be a good play. I wouldn't bet on it though. Much easier ways to make money in this market.

Sarugaser had some words about two issues, namely, what he called the company’s bloated SG&A and the new convertible debt financing. On the former, the analyst said he’d like to see Auxly’s costs come more in line with its cannabis peers, while on the latter he said the terms of the financing are, in fact, “quite onerous.”

“While our estimate of the total potential dilution from this convertible debt facility is 136.9 million shares—an inordinate amount of dilution in our view—management has reflected that between growth of top-line revenue, increasing gross margins, and controlling costs, they should be able to mitigate further draws on the facility. We give them the benefit of the doubt, adding only the potential dilution from the currently drawn $9.5 million, and remain cautiously optimistic that management should succeed in sourcing less dilutive forms of financing to meet XLY's working capital needs,” Sarugaser wrote.

 

Bullboard Posts